
Arcus Biosciences: Anti-TIGIT Therapy On Track With ARC-7 Results (NYSE:RCUS)
AzmanJaka/E+ via Getty Images Arcus Biosciences (NYSE:RCUS) is a biopharmaceutical company specializing in cancer therapeutics that are operating at the clinical stage. Their lead candidate, domvanalimab, has displayed potential through trials for metastatic non-small cell […]